Simon F. Lacey

Children's Hospital of Philadelphia — United States

Medicine · Health Sciences

75h-index37.7kcitations379works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(244), Acute Lymphoblastic Leukemia research(61), Immune Cell Function and Interaction(57), Cytomegalovirus and herpesvirus research(40), Immunotherapy and Immune Responses(39)

Publications379 total

<i>Neisseria meningitidis</i> bacteraemia and lobar pneumonia in a previously healthy, fully immunised (including meningococcal vaccines) Irish teenager
BMJ Case Reports·2025Open Access
Supplementary Tables and Figures from Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy
2025Open Access
1. Discovering Nuclear Vs. Cytoplasmic Roles of ESRP1 and ESRP2 RNA Splicing Regulators in Craniofacial Development
Plastic & Reconstructive Surgery Global Open·2025Open Access
41. Discovering Nuclear Vs. Cytoplasmic Roles of Esrp1 and Esrp2 RNA Splicing Regulators in Craniofacial Development.
Plastic & Reconstructive Surgery Global Open·2025Open Access
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication
Journal of Clinical Investigation·2024· 4 citedOpen Access
Two cases of severe pulmonary toxicity from highly active mesothelin-directed CAR T cells
Molecular Therapy·2023· 78 citedOpen Access
Data from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
TABLE 3 from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
TABLE 5 from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
TABLE 4 from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
FIGURE 1 from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
FIGURE 2 from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
Supplementary Figure 2 from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
TABLE 5 from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
Supplementary Figure 1 from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
TABLE 2 from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
Supplementary Figure 2 from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
Supplementary Figure 1 from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
TABLE 4 from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
Data from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
2023Open Access
page 1 of 19Next →

Frequent Co-authors

Carl H. June(41), J. Joseph Melenhorst(33), Bruce L. Levine(28), Stephan A. Grupp(18), Shannon L. Maude(17), David L. Porter(15), Noelle V. Frey(14), Irina Kulikovskaya(12), Joseph A. Fraietta(11), Regina M. Young(11), Saar Gill(11), Wei‐Ting Hwang(10), David T. Teachey(9), Marco Ruella(9), Farzana Nazimuddin(9), Pamela A. Shaw(8), David M. Barrett(8), Vanessa Gonzalez(8), Gabriela Plesa(8), Megan M. Davis(8)